English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [916]
News [2620]
Articles [112]
Editorials [3]
Conferences [85]
elearning [27]
Drug-delivery technique for brain cancer shows growing promise
Drug-delivery technique for brain cancer shows growing promise
Research finds non-small cell lung cancer drug lorlatinib targets additional protein
Research finds non-small cell lung cancer drug lorlatinib targets additional protein
PET imaging validates use of common cholesterol drug to enhance HER2-targeted cancer therapy
PET imaging validates use of common cholesterol drug to enhance HER2-targeted cancer therapy
Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy
Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy
From prevention to treatment: new hope for genomics in the global fight against cancer
From prevention to treatment: new hope for genomics in the global fight against cancer
Ultrasound-activated chemotherapy advances therapeutic potential for deep tumours
Ultrasound-activated chemotherapy advances therapeutic potential for deep tumours
Majority of cancer patients interested in complementary therapies for treatment
Majority of cancer patients interested in complementary therapies for treatment
Novel drug, NFX-179, inhibits MEK activity, prevents cutaneous squamous cell carcinoma development
Novel drug, NFX-179, inhibits MEK activity, prevents cutaneous squamous cell carcinoma development
FDA approves encorafenib with binimetinib for metastatic non-small cell lung cancer with a BRAF V600E mutation
FDA approves encorafenib with binimetinib for metastatic non-small cell lung cancer with a BRAF V600E mutation
Primary care reminder plus patient outreach intervention improved rates of follow-up after abnormal cancer test results
Primary care reminder plus patient outreach intervention improved rates of follow-up after abnormal cancer test...
<1...2425262728...262>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top